Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium

C. Bosetti, V. Rosato, D. Li, D. Silverman, G. M. Petersen, P. M. Bracci, R. E. Neale, J. Muscat, K. Anderson, S. Gallinger, S. H. Olson, A. B. Miller, H. Bas Bueno-de-Mesquita, G. Scelo, V. Janout, I. Holcatova, P. Lagiou, D. Serraino, E. Lucenteforte, E. FabianovaP. A. Baghurst, W. Zatonski, L. Foretova, E. Fontham, W. R. Bamlet, E. A. Holly, E. Negri, M. Hassan, A. Prizment, M. Cotterchio, S. Cleary, R. C. Kurtz, P. Maisonneuve, D. Trichopoulos, J. Polesel, E. J. Duell, P. Boffetta, C. La Vecchia, P. Ghadirian

Research output: Contribution to journal › Article › peer-review

117 Scopus citations

Fingerprint

Dive into the research topics of 'Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium'. Together they form a unique fingerprint.

Medicine & Life Sciences